{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:40:29Z","timestamp":1791772829515,"version":"4.3.4"},"reference-count":171,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024QH124"],"award-info":[{"award-number":["ZR2024QH124"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Multiple sclerosis (MS) is a complex multifactorial disease of the central nervous system (CNS) whose pathogenesis has not yet been fully elucidated. Current MS treatments primarily consist of disease-modifying therapies with anti-inflammatory and immunomodulatory properties, which effectively reduce relapse rates and disease activity. However, these therapies often exhibit limited long-term efficacy, may cause severe adverse effects, and remain largely insufficient in preventing the progressive accumulation of irreversible disability driven by axonal and neuronal damage. Although oxidative stress (OS) is not the sole pathologic factor in MS, substantial evidence supports its critical contribution to disease development and progression. In particular, OS is closely associated with key pathological processes such as demyelination and axonal degeneration. OS can act as a signaling mediator that promotes inflammatory responses, while inflammatory processes further amplify OS, forming a self-perpetuating cycle that exacerbates CNS tissue injury. Consequently, increasing attention has been directed toward the development of antioxidant-based therapeutic strategies for MS. Nevertheless, a comprehensive synthesis of MS drug development from the perspective of antioxidant capacity remains lacking, limiting rational therapeutic. This review examines the interplay between inflammation and OS in MS pathology, and summarizes current advances in antioxidant-based therapeutic approaches. By integrating existing evidence, this work aims to clarify the role of OS in MS pathogenesis and to inform the development of effective antioxidant-oriented treatments.<\/jats:p>","DOI":"10.3389\/fphar.2026.1806176","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:25:27Z","timestamp":1776662727000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The oxidative stress-inflammation self-perpetuating cycle in multiple sclerosis: from mechanisms to emerging antioxidant strategies"],"prefix":"10.3389","volume":"17","author":[{"given":"Baiyang","family":"Yuan","sequence":"first","affiliation":[{"name":"School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Jin","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Shen","sequence":"additional","affiliation":[{"name":"Shanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Tian","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Duan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"133941","DOI":"10.1016\/j.ijbiomac.2024.133941","article-title":"Catalase immobilization: current knowledge, key insights, applications, and future prospects - a review","volume":"276","author":"Abdalbagemohammedabdalsadeg","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.apsb.2015.05.008","article-title":"Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents","volume":"5","author":"Abed","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"B3","doi-asserted-by":"publisher","first-page":"118600","DOI":"10.1016\/j.atherosclerosis.2024.118600","article-title":"Metabolites derived from radical oxidation of PUFA: neo-pufas, promising molecules for health?","volume":"398","author":"Abramova","year":"2024","journal-title":"Atherosclerosis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ng.2770","article-title":"Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis","volume":"45","author":"Beecham","year":"2013","journal-title":"Nat. Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.freeradbiomed.2025.09.052","article-title":"Oxidative stress and multiple sclerosis: trajectories and possible predictive activities of pro and antioxidant biomolecules","volume":"241","author":"Bellisario","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/antiox12081638","article-title":"Exploring the relationship between antioxidant enzymes, oxidative stress markers, and clinical profile in relapsing-remitting multiple sclerosis","volume":"12","author":"Bizon","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s40265-019-01229-3","article-title":"Dimethyl fumarate: a review in relapsing-remitting MS","volume":"79","author":"Blair","year":"2019","journal-title":"Drugs"},{"key":"B11","doi-asserted-by":"publisher","first-page":"rs10","DOI":"10.1126\/scisignal.aaf7694","article-title":"Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells","volume":"9","author":"Blewett","year":"2016","journal-title":"Sci. Signal"},{"key":"B12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ana.410360515","article-title":"Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains","volume":"36","author":"Bo","year":"1994","journal-title":"Ann. Neurol."},{"key":"B13","first-page":"119","article-title":"Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis","volume":"14","author":"Calabrese","year":"1994","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.22109","article-title":"Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis","volume":"69","author":"Campbell","year":"2011","journal-title":"Ann. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"287ra274","DOI":"10.1126\/scitranslmed.aaa8038","article-title":"Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis","volume":"7","author":"Cao","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"a040543","DOI":"10.1101\/cshperspect.a040543","article-title":"Mitochondria","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"117084","DOI":"10.1016\/j.biopha.2024.117084","article-title":"New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases","volume":"178","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/1352458510384010","article-title":"Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T","volume":"17","author":"Choi","year":"2011","journal-title":"Mult. Scler."},{"key":"B19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/1352458516669441","article-title":"Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis","volume":"23","author":"Choi","year":"2017","journal-title":"Mult. Scler."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosi","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","article-title":"Relapses and progression of disability in multiple sclerosis","volume":"343","author":"Confavreux","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/s0306-9877(97)90196-1","article-title":"Multiple sclerosis: an immune legacy?","volume":"49","author":"Cooper","year":"1997","journal-title":"Med. Hypotheses"},{"key":"B23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/biomedicines7010014","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis","volume":"7","author":"Correale","year":"2019","journal-title":"Biomedicines"},{"key":"B24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1124\/pr.117.014753","article-title":"Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach","volume":"70","author":"Cuadrado","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.tips.2020.07.003","article-title":"Can activation of NRF2 be a strategy against COVID-19?","volume":"41","author":"Cuadrado","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"B27","first-page":"1281","article-title":"Cu\/Zn-superoxide dismutase and glutathione peroxidase during aging","volume":"35","author":"de Haan","year":"1995","journal-title":"Biochem. Mol. Biol. Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.freeradbiomed.2008.09.001","article-title":"Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?","volume":"45","author":"de Vries","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.tips.2022.12.003","article-title":"Advances and challenges in therapeutic targeting of NRF2","volume":"44","author":"Dinkova-Kostova","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1073\/pnas.0500815102","article-title":"Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress","volume":"102","author":"Dinkova-Kostova","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis - a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in disease: timing is everything","volume":"59","author":"Dodson","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.redox.2016.10.003","article-title":"Nrf2 mediates redox adaptations to exercise","volume":"10","author":"Done","year":"2016","journal-title":"Redox Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1056\/NEJMc1211805","article-title":"PML in a patient treated with fumaric acid","volume":"368","author":"Ermis","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1002\/anie.201107724","article-title":"Curcumin-from molecule to biological function","volume":"51","author":"Esatbeyoglu","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s13311-016-0480-0","article-title":"Lipopolysaccharide binding protein and oxidative stress in a multiple sclerosis model","volume":"14","author":"Escribano","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1474-4422(20)30063-6","article-title":"Rethinking multiple sclerosis treatment strategies","volume":"19","author":"Filippi","year":"2020","journal-title":"Lancet Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiples sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1083\/jcb.201102095","article-title":"Signal transduction by reactive oxygen species","volume":"194","author":"Finkel","year":"2011","journal-title":"J. Cell Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/brain\/aws012","article-title":"NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury","volume":"135","author":"Fischer","year":"2012","journal-title":"Brain"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","article-title":"Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis","volume":"367","author":"Fox","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1016\/j.neuron.2022.09.023","article-title":"CNS remyelination and inflammation: from basic mechanisms to therapeutic opportunities","volume":"110","author":"Franklin","year":"2022","journal-title":"Neuron"},{"key":"B44","doi-asserted-by":"publisher","first-page":"h1765","DOI":"10.1136\/bmj.h1765","article-title":"Relapse in multiple sclerosis","volume":"350","author":"Galea","year":"2015","journal-title":"BMJ"},{"key":"B45","doi-asserted-by":"publisher","first-page":"eadk3434","DOI":"10.1126\/scitranslmed.adk3434","article-title":"The protein kinase C modulator bryostatin-1 therapeutically targets microglia to attenuate neuroinflammation and promote remyelination","volume":"17","author":"Gharibani","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/s0028-3908(01)00019-3","article-title":"Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier","volume":"40","author":"Gilgun-Sherki","year":"2001","journal-title":"Neuropharmacology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1750-3639.2007.00110.x","article-title":"Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis","volume":"18","author":"Gray","year":"2008","journal-title":"Brain Pathol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2015.02.023","article-title":"Dietary polyunsaturated fatty acids and heme iron induce oxidative stress biomarkers and a cancer promoting environment in the colon of rats","volume":"83","author":"Gueraud","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"725370","DOI":"10.1155\/2015\/725370","article-title":"Inflammation, Iron, energy failure, and oxidative stress in the pathogenesis of multiple sclerosis","volume":"2015","author":"Haider","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/brain\/awr128","article-title":"Oxidative damage in multiple sclerosis lesions","volume":"134","author":"Haider","year":"2011","journal-title":"Brain"},{"key":"B53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","article-title":"Single-Cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"key":"B54","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jneuroim.2004.02.005","article-title":"Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage","volume":"151","author":"Hill","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/BF00988606","article-title":"Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients","volume":"10","author":"Hunter","year":"1985","journal-title":"Neurochem. Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2217\/bmm-2016-0097","article-title":"Oxidative stress-related biomarkers in multiple sclerosis: a review","volume":"10","author":"Ibitoye","year":"2016","journal-title":"Biomark. Med."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","year":"2019","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.4049\/jimmunol.175.10.6968","article-title":"Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema","volume":"175","author":"Ishii","year":"2005","journal-title":"J. Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1128\/MCB.24.1.36-45.2004","article-title":"Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2)","volume":"24","author":"Itoh","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"CD008422","DOI":"10.1002\/14651858.CD008422.pub3","article-title":"Vitamin D for the management of multiple sclerosis","volume":"9","author":"Jagannath","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","article-title":"Altered human oligodendrocyte heterogeneity in multiple sclerosis","volume":"566","author":"Jakel","year":"2019","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"980758","DOI":"10.3389\/fneur.2022.980758","article-title":"Impact of histone modifier-induced protection against autoimmune encephalomyelitis on multiple sclerosis treatment","volume":"13","author":"Jayaraman","year":"2022","journal-title":"Front. Neurol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1089\/ars.2024.0586","article-title":"Adverse effects of Nrf2 in different organs and the related diseases","volume":"42","author":"Jin","year":"2025","journal-title":"Antioxid. Redox Signal"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","article-title":"Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants","volume":"98","author":"Jomova","year":"2024","journal-title":"Arch. Toxicol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"148142","DOI":"10.1016\/j.ijbiomac.2025.148142","article-title":"Molecular interplay between oxidative and endoplasmic reticulum stress in multiple sclerosis","volume":"330","author":"Kamarehei","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.autrev.2009.08.002","article-title":"The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis","volume":"9","author":"Kaushansky","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"B69","doi-asserted-by":"publisher","first-page":"12169","DOI":"10.1073\/pnas.1509158112","article-title":"Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation","volume":"112","author":"Keleku-Lukwete","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B70","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.brainres.2016.04.027","article-title":"Oxidative injury in multiple sclerosis cerebellar grey matter","volume":"1642","author":"Kemp","year":"2016","journal-title":"Brain Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway","volume":"47","author":"Kensler","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"11312","DOI":"10.1038\/ncomms11312","article-title":"An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination","volume":"7","author":"Keough","year":"2016","journal-title":"Nat. Commun."},{"key":"B73","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/acn3.251","article-title":"Dimethyl fumarate inhibits integrin alpha4 expression in multiple sclerosis models","volume":"2","author":"Kihara","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00281-021-00907-3","article-title":"Genetics and functional genomics of multiple sclerosis","volume":"44","author":"Kim","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3390\/antiox13121462","article-title":"Role of oxidative stress in blood-brain barrier disruption and neurodegenerative diseases","volume":"13","author":"Kim","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41582-023-00801-6","article-title":"Inflammation in multiple sclerosis: consequences for remyelination and disease progression","volume":"19","author":"Klotz","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"key":"B78","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/135245850000600306","article-title":"The Danish National Project of interferon-beta treatment in relapsing-remitting multiple sclerosis. The Danish Multiple Sclerosis Group","volume":"6","author":"Koch-Henriksen","year":"2000","journal-title":"Mult. Scler."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1152\/physrev.00034.2023","article-title":"NADPH oxidases: redox regulation of cell homeostasis and disease","volume":"105","author":"Kracun","year":"2025","journal-title":"Physiol. Rev."},{"key":"B80","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/glia.22597","article-title":"Mechanisms of white matter damage in multiple sclerosis","volume":"62","author":"Lassmann","year":"2014","journal-title":"Glia"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic mechanisms associated with different clinical courses of multiple sclerosis","volume":"9","author":"Lassmann","year":"2018","journal-title":"Front. Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40265-023-01874-9","article-title":"Omaveloxolone: first approval","volume":"83","author":"Lee","year":"2023","journal-title":"Drugs"},{"key":"B85","doi-asserted-by":"publisher","first-page":"103807","DOI":"10.1016\/j.redox.2025.103807","article-title":"NOX-NOS crosstalk in the liver-brain axis: novel insights for redox regulation and neurodegenerative diseases","volume":"86","author":"Lee","year":"2025","journal-title":"Redox Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/cells13020116","article-title":"Mechanisms governing oligodendrocyte viability in multiple sclerosis and its animal models","volume":"13","author":"Lei","year":"2024","journal-title":"Cells"},{"key":"B87","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.4049\/jimmunol.154.9.4379","article-title":"T cell gelatinases mediate basement membrane transmigration in vitro","volume":"154","author":"Leppert","year":"1995","journal-title":"J. Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.bcp.2008.07.017","article-title":"Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis","volume":"76","author":"Li","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.freeradbiomed.2018.09.018","article-title":"Enhancing the activity and stability of Mn-superoxide dismutase by one-by-one ligation to catalase","volume":"129","author":"Li","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2023.07.032","article-title":"Reactive nitrogen species as therapeutic targets for autophagy\/mitophagy modulation to relieve neurodegeneration in multiple sclerosis: potential application for drug discovery","volume":"208","author":"Li","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00401-015-1452-x","article-title":"Cell type-specific Nrf2 expression in multiple sclerosis lesions","volume":"130","author":"Licht-Mayer","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"B93","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3109\/1061186X.2016.1157883","article-title":"Oral bioavailability of curcumin: problems and advancements","volume":"24","author":"Liu","year":"2016","journal-title":"J. Drug Target"},{"key":"B94","doi-asserted-by":"publisher","first-page":"188890","DOI":"10.1016\/j.bbcan.2023.188890","article-title":"GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"B96","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41423-022-00883-0","article-title":"Ferroptosis promotes T-cell activation-induced neurodegeneration in multiple sclerosis","volume":"19","author":"Luoqian","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1074\/jbc.M106685200","article-title":"Chemoprotection by phenolic antioxidants. Inhibition of tumor necrosis factor alpha induction in macrophages","volume":"277","author":"Ma","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.2353\/ajpath.2006.051113","article-title":"Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2","volume":"168","author":"Ma","year":"2006","journal-title":"Am. J. Pathol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41419-023-06234-9","article-title":"Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 Pathway activation and attenuating inflammatory signaling","volume":"14","author":"Ma","year":"2023","journal-title":"Cell Death Dis."},{"key":"B101","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.7150\/thno.114836","article-title":"Antioxidant nanozymes: current status and future perspectives in spinal cord injury treatments","volume":"15","author":"Ma","year":"2025","journal-title":"Theranostics"},{"key":"B102","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/med.21257","article-title":"Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents","volume":"32","author":"Magesh","year":"2012","journal-title":"Med. Res. Rev."},{"key":"B103","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.freeradbiomed.2015.02.017","article-title":"Understanding mammalian glutathione peroxidase 7 in the light of its homologs","volume":"83","author":"Maiorino","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1001\/jama.2022.14236","article-title":"What is multiple sclerosis?","volume":"328","author":"Marcus","year":"2022","journal-title":"JAMA"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.3390\/cells11233855","article-title":"Induction of cardiac pathology: endogenous versus exogenous Nrf2 upregulation","volume":"11","author":"Mathis","year":"2022","journal-title":"Cells"},{"key":"B106","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/brbi.1997.0496","article-title":"Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species","volume":"11","author":"Merrill","year":"1997","journal-title":"Brain Behav. Immun."},{"key":"B107","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuropharm.2015.07.013","article-title":"Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair","volume":"99","author":"Mohajeri","year":"2015","journal-title":"Neuropharmacology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.drudis.2011.12.020","article-title":"Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival","volume":"17","author":"Morgan","year":"2012","journal-title":"Drug Discov. Today"},{"key":"B109","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/clinchem\/38.12.2449","article-title":"Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions","volume":"38","author":"Naidoo","year":"1992","journal-title":"Clin. Chem."},{"key":"B110","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40263-020-00700-0","article-title":"Diroximel fumarate demonstrates an improved gastrointestinal tolerability profile compared with Dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: results from the randomized, Double-Blind, phase III EVOLVE-MS-2 Study","volume":"34","author":"Naismith","year":"2020","journal-title":"CNS Drugs"},{"key":"B111","doi-asserted-by":"publisher","first-page":"102816","DOI":"10.1016\/j.msard.2021.102816","article-title":"Clinical features of late-onset multiple sclerosis: a systematic review and meta-analysis","volume":"50","author":"Naseri","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B112","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/s0165-5728(99)00247-7","article-title":"1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis","volume":"103","author":"Nashold","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/s0165-5728(01)00360-5","article-title":"Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis","volume":"119","author":"Nashold","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1007\/s12035-022-02755-0","article-title":"Therapeutic potential of combined therapy of vitamin A and vitamin C in the Experimental Autoimmune Encephalomyelitis (EAE) in lewis rats","volume":"59","author":"Navidhamidi","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1179\/1476830513Y.0000000083","article-title":"Modulation of oxidative stress, apoptosis, and calcium entry in leukocytes of patients with multiple sclerosis by Hypericum perforatum","volume":"17","author":"Naziroglu","year":"2014","journal-title":"Nutr. Neurosci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: central and peripheral mode of action","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp. Neurol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1401156","DOI":"10.3389\/fimmu.2024.1401156","article-title":"High heterogeneity of cross-reactive immunoglobulins in multiple sclerosis presumes combining of B-cell epitopes for diagnostics: a case-control study","volume":"15","author":"Ovchinnikova","year":"2024","journal-title":"Front. Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/10408398.2018.1552244","article-title":"Cellular and molecular mechanisms of curcumin in prevention and treatment of disease","volume":"60","author":"Patel","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B119","doi-asserted-by":"publisher","first-page":"7191080","DOI":"10.1155\/2020\/7191080","article-title":"Inflammation and oxidative stress in multiple sclerosis: consequences for therapy development","volume":"2020","author":"Pegoretti","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"B120","doi-asserted-by":"publisher","first-page":"28017","DOI":"10.1074\/jbc.M112.383380","article-title":"Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor kappaB (NF-kappaB) and extracellular signal-regulated kinase 1 and 2 (ERK1\/2) and mitogen stress-activated kinase 1 (MSK1) signaling","volume":"287","author":"Peng","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1021\/jm501535r","article-title":"CNS drug design: balancing physicochemical properties for optimal brain exposure","volume":"58","author":"Rankovic","year":"2015","journal-title":"J. Med. Chem."},{"key":"B123","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/(SICI)1099-081X(199603)17:2<165::AID-BDD945>3.0.CO;2-N","article-title":"Pharmacokinetics of superoxide dismutase in rats after oral administration","volume":"17","author":"Regnault","year":"1996","journal-title":"Biopharm. Drug Dispos."},{"key":"B124","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12031-016-0781-0","article-title":"The molecular mechanisms of vitamin A deficiency in multiple sclerosis","volume":"60","author":"Reza Dorosty-Motlagh","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"9372182","DOI":"10.1155\/2019\/9372182","article-title":"Activators and inhibitors of NRF2: a review of their potential for clinical development","volume":"2019","author":"Robledinos-Anton","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"B127","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1750-3639.1994.tb00825.x","article-title":"Extracellular matrix-degrading proteinases in the nervous system","volume":"4","author":"Romanic","year":"1994","journal-title":"Brain Pathol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1056\/NEJMc1415408","article-title":"PML in a patient with lymphocytopenia treated with dimethyl fumarate","volume":"372","author":"Rosenkranz","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B129","doi-asserted-by":"publisher","first-page":"167764","DOI":"10.1016\/j.bbadis.2025.167764","article-title":"Activation, interaction and intimation of Nrf2 pathway and their mutational studies causing Nrf2 associated cancer","volume":"1871","author":"Sahu","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B130","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1515\/revneuro-2023-0091","article-title":"Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review","volume":"35","author":"Sanabria-Castro","year":"2024","journal-title":"Rev. Neurosci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12883-022-02761-8","article-title":"Comparison of dimethyl fumarate and interferon outcomes in an MS cohort","volume":"22","author":"Sattarnezhad","year":"2022","journal-title":"BMC Neurol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1212\/WNL.0b013e318230a17d","article-title":"Age and disability accumulation in multiple sclerosis","volume":"77","author":"Scalfari","year":"2011","journal-title":"Neurology"},{"key":"B133","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1073\/pnas.1603907113","article-title":"Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2","volume":"113","author":"Schulze-Topphoff","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/ptr.7754","article-title":"Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: therapeutic and biotechnological prospects","volume":"37","author":"Shahcheraghi","year":"2023","journal-title":"Phytother. Res."},{"key":"B135","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/WNO.0b013e3181f7f833","article-title":"Oral resveratrol reduces neuronal damage in a model of multiple sclerosis","volume":"30","author":"Shindler","year":"2010","journal-title":"J. Neuroophthalmol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"a020479","DOI":"10.1101\/cshperspect.a020479","article-title":"Oligodendrocytes: myelination and axonal support","volume":"8","author":"Simons","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1124\/mol.107.038984","article-title":"Resveratrol (trans-3,5,4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor","volume":"72","author":"Singh","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12974-017-0831-8","article-title":"Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis","volume":"14","author":"Singh","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"B140","doi-asserted-by":"publisher","first-page":"e14064","DOI":"10.1111\/acel.14064","article-title":"SKN-1\/NRF2 upregulation by vitamin A is conserved from nematodes to mammals and is critical for lifespan extension in Caenorhabditis elegans","volume":"23","author":"Sirakawin","year":"2024","journal-title":"Aging Cell"},{"key":"B141","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2022.10.003","article-title":"The role of vitamin D on redox regulation and cellular senescence","volume":"193","author":"Sosa-Diaz","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nri2548","article-title":"A molecular trio in relapse and remission in multiple sclerosis","volume":"9","author":"Steinman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-Brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"key":"B145","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1600-065X.2012.01127.x","article-title":"Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models","volume":"248","author":"Takeshita","year":"2012","journal-title":"Immunol. Rev."},{"key":"B146","doi-asserted-by":"publisher","first-page":"17500","DOI":"10.1073\/pnas.0708710104","article-title":"Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation","volume":"104","author":"Talalay","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B147","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.clinbiochem.2012.01.023","article-title":"Peripheral oxidative stress in relapsing-remitting multiple sclerosis","volume":"45","author":"Tasset","year":"2012","journal-title":"Clin. Biochem."},{"key":"B148","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s12031-020-01672-y","article-title":"Oxidative\/Nitroxidative stress and multiple sclerosis","volume":"71","author":"Tobore","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional regulation by Nrf2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxid. Redox Signal"},{"key":"B150","doi-asserted-by":"publisher","first-page":"17223","DOI":"10.3390\/ijms242417223","article-title":"Oxidative stress and the nuclear factor erythroid 2-Related factor 2 (Nrf2) pathway in multiple sclerosis: focus on certain exogenous and endogenous Nrf2 activators and therapeutic Plasma exchange modulation","volume":"24","author":"Tonev","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","article-title":"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model","volume":"26","author":"Tong","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S1474-4422(09)70043-2","article-title":"Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis","volume":"8","author":"Trapp","year":"2009","journal-title":"Lancet Neurol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.freeradbiomed.2008.09.023","article-title":"Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression","volume":"45","author":"van Horssen","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.freeradbiomed.2010.07.013","article-title":"Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions","volume":"49","author":"van Horssen","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"B155","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/s41418-023-01195-0","article-title":"Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression","volume":"30","author":"Van San","year":"2023","journal-title":"Cell Death Differ."},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18040760","article-title":"Expression of the antioxidative enzyme Peroxiredoxin 2 in multiple sclerosis lesions in relation to inflammation","volume":"18","author":"Voigt","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B157","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1749-6632.2010.05842.x","article-title":"Bioavailability of resveratrol","volume":"1215","author":"Walle","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/s1054-3589(08)60993-x","article-title":"Antioxidants, redox-regulated transcription factors, and inflammation","volume":"38","author":"Winyard","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"103240","DOI":"10.1016\/j.redox.2024.103240","article-title":"Peroxynitrite reduces Treg cell expansion and function by mediating IL-2R nitration and aggravates multiple sclerosis pathogenesis","volume":"75","author":"Wu","year":"2024","journal-title":"Redox Biol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s12276-022-00829-6","article-title":"The Nrf2 antioxidant defense system in intervertebral disc degeneration: molecular insights","volume":"54","author":"Xiang","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.intimp.2009.01.025","article-title":"Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production","volume":"9","author":"Xie","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1038\/sj.onc.1208656","article-title":"Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells","volume":"24","author":"Xu","year":"2005","journal-title":"Oncogene"},{"key":"B163","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/ars.2014.5962","article-title":"Frequency modulated translocational oscillations of Nrf2 mediate the antioxidant response element cytoprotective transcriptional response","volume":"23","author":"Xue","year":"2015","journal-title":"Antioxid. Redox Signal"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 System: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"key":"B165","doi-asserted-by":"publisher","first-page":"101963","DOI":"10.1016\/j.mtbio.2025.101963","article-title":"Advancing cancer therapy: Nanomaterial-based encapsulation strategies for enhanced delivery and efficacy of curcumin","volume":"33","author":"Yan","year":"2025","journal-title":"Mater Today Bio"},{"key":"B166","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1021\/acs.chemrev.8b00626","article-title":"Reactive oxygen species (ROS)-Based nanomedicine","volume":"119","author":"Yang","year":"2019","journal-title":"Chem. Rev."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1046\/j.1523-1755.2001.00939.x","article-title":"Nrf2-deficient female mice develop lupus-like autoimmune nephritis","volume":"60","author":"Yoh","year":"2001","journal-title":"Kidney Int."},{"key":"B168","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.bbrc.2007.05.007","article-title":"A fused selenium-containing protein with both GPx and SOD activities","volume":"358","author":"Yu","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B169","doi-asserted-by":"publisher","first-page":"14423","DOI":"10.3390\/ijms232214423","article-title":"1,2,3,4,6-O-Pentagalloylglucose protects against Acute lung injury by activating the AMPK\/PI3K\/Akt\/Nrf2 pathway","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B170","doi-asserted-by":"publisher","first-page":"103823","DOI":"10.1016\/j.autrev.2025.103823","article-title":"Rebalancing redox homeostasis: a pivotal regulator of the cGAS-STING pathway in autoimmune diseases","volume":"24","author":"Zhao","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"B171","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1806176\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:25:29Z","timestamp":1776662729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1806176\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":171,"alternative-id":["10.3389\/fphar.2026.1806176"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1806176","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1806176"}}